Orthopedic devices include hip, knee, and shoulder reconstruction implants, spine fusion hardware, trauma plates and screws, sports medicine soft-tissue repair, and orthobiologics. Robotics-assisted surgery is an increasingly important sub-segment. The segment includes joint replacement, trauma, sports medicine and spine, with large volumes of implants and instruments. Many implants reach market through 510(k), and hospital purchasing relies on price contracts and bundled payment programs. Robotics and navigation are increasingly used in joint surgery.

Why it matters

Stryker, Zimmer Biomet, J&J DePuy Synthes, Smith+Nephew, and Globus/NuVasive lead the segment. Procedure-volume tied to demographics; ASC migration is reshaping economics.

Common pitfalls

•One common pitfall is failing to adequately address biocompatibility requirements for implantable orthopedic devices, as outlined in ISO 10993 series standards.
•Another mistake is underestimating the complexity of clinical data requirements for high-risk orthopedic implants, especially under the EU MDR.
•Manufacturers sometimes overlook the specific post-market surveillance obligations for orthopedic devices, which include monitoring long-term performance and adverse events.

Sources

AAOS · AAOS
AdvaMed - Industry Reports · AdvaMed
MedTech Europe - Facts & Figures · MedTech Europe
OHT6: Office of Orthopedic Devices · FDA

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.